Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk

Diepold, Miriam; Noellke, Peter; Duffner, Ulrich; Kontny, Udo; Berner, Reinhard (2008). Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk. BMC infectious diseases, 8, p. 28. London: BioMed Central 10.1186/1471-2334-8-28

[img]
Preview
Text
2.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (282kB) | Preview

BACKGROUND: Patients with chemotherapy-related neutropenia and fever are usually hospitalized and treated on empirical intravenous broad-spectrum antibiotic regimens. Early diagnosis of sepsis in children with febrile neutropenia remains difficult due to non-specific clinical and laboratory signs of infection. We aimed to analyze whether IL-6 and IL-8 could define a group of patients at low risk of septicemia. METHODS: A prospective study was performed to assess the potential value of IL-6, IL-8 and C-reactive protein serum levels to predict severe bacterial infection or bacteremia in febrile neutropenic children with cancer during chemotherapy. Statistical test used: Friedman test, Wilcoxon-Test, Kruskal-Wallis H test, Mann-Whitney U-Test and Receiver Operating Characteristics. RESULTS: The analysis of cytokine levels measured at the onset of fever indicated that IL-6 and IL-8 are useful to define a possible group of patients with low risk of sepsis. In predicting bacteremia or severe bacterial infection, IL-6 was the best predictor with the optimum IL-6 cut-off level of 42 pg/ml showing a high sensitivity (90%) and specificity (85%). CONCLUSION: These findings may have clinical implications for risk-based antimicrobial treatment strategies.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine

UniBE Contributor:

Diepold, Miriam

ISSN:

1471-2334

ISBN:

18321393

Publisher:

BioMed Central

Language:

English

Submitter:

Anette van Dorland

Date Deposited:

04 Oct 2013 15:03

Last Modified:

05 Dec 2022 14:19

Publisher DOI:

10.1186/1471-2334-8-28

PubMed ID:

18321393

Web of Science ID:

000254971700001

BORIS DOI:

10.7892/boris.27183

URI:

https://boris.unibe.ch/id/eprint/27183 (FactScience: 104897)

Actions (login required)

Edit item Edit item
Provide Feedback